Report - HECHO RELEVANTE NEURON BIOPHARMA, S.A. · MARKETS: Global Central Nervous System (CNS) market: $71 billion in 2010 • Neurodegenerative disorders market: >$21 billion in 2009 •

Please pass captcha verification before submit form